Paclitaxel
- 1 lab in 1 country
- 1,497 trials, 291 with no results posted
- Funders: Australian Research Council and 2 more
- Human trial1
Outcomes
1Superovulation
downin mice1
1 study
Superovulation
downin mice1
Paclitaxel impairs superovulation in mice.
“In older mice, paclitaxel and carboplatin impaired superovulation and reduced the yield of mature (metaphase II) oocytes in cKO mice”
Animalsin Brca1 cKO mice
Reproductive biomedicine online24 Jul 2026
Trial sponsors
Company41 trialsPhase 423,369 people
Company31 trialsPhase 420,805 people
Novartis Pharmaceuticals Corporation
Company11 trialsPhase 42,489 people
Nanjing NingQi Medicine Science and Technology
Company2 trialsPhase 4768 people
Company1 trialPhase 45 people
Company19 trialsPhase 311,155 people
Company13 trialsPhase 37,430 people
Company10 trialsPhase 32,642 people
Latest
3 in 12 monthsBMC Sports Science, Medicine & Rehabilitation
Feasibility of an exercise intervention for chemotherapy-related fatigue in patients with gynecologic cancer: a randomized controlled trial with multidimensional assessment
Randomised trial in 110 peopleExercise
Reproductive Biomedicine Online
BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice
Experiments in miceBRCA1
bioRxiv
Senescent peripheral fibroblasts initiate chemotherapy-induced peripheral neuropathy
Preprint: experiments in animalsCellular senescence
Lancet
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
Randomised trial in 1,800 peopleInterventions